Cardinal Health (NYSE: CAH) accounting chief sells 2,302 shares

Rhea-AI Filing Summary

CARDINAL HEALTH INC (CAH) reported that Chief Accounting Officer Mary C. Scherer sold a total of 2,302 Common Shares on 2026-08-19 in open market or private transactions. The sales occurred in two tranches: 100 shares at $237.40 per share and 2,202 shares at $237.39 per share. The filing does not state her share holdings after these transactions, and the Rule 10b5-1 checkbox was left unchecked.

Insider Trade Summary

Net Seller: 2,302 shares

Net Sell 2 txns

Insider Scherer Mary C.

Role Chief Accounting Officer

Sold 2,302 shs ($546K)

Type	Security	Shares	Price	Value
Sale	Common Shares	100	$237.40	$24K
Sale	Common Shares	2,202	$237.39	$523K

Holdings After Transaction: Common Shares — 2,811 shares (Direct)

Key Figures

Total shares sold: 2,302 Common Shares Sale price per share (first tranche): $237.40 per share Sale price per share (second tranche): $237.39 per share +1 more

4 metrics

Total shares sold 2,302 Common Shares Aggregate shares sold by Mary C. Scherer on 2026-08-19

Sale price per share (first tranche) $237.40 per share 100 Common Shares sold on 2026-08-19

Sale price per share (second tranche) $237.39 per share 2,202 Common Shares sold on 2026-08-19

Number of sale transactions 2 Two non-derivative sales of Common Shares reported

Key Terms

Form 4, Rule 10b5-1, open market or private transaction

3 terms

Form 4 regulatory

"What insider transaction did CAH report for Mary C. Scherer on this Form 4?"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Rule 10b5-1 regulatory

"the Rule 10b5-1 checkbox was left unchecked"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

What insider transaction did CAH report for Mary C. Scherer on this Form 4?

The report shows that Chief Accounting Officer Mary C. Scherer sold 2,302 Common Shares of CARDINAL HEALTH INC (CAH) on 2026-08-19 in open market or private transactions.

At what prices were the CAH shares sold by Mary C. Scherer?

Mary C. Scherer sold 100 CAH shares at $237.40 per share and 2,202 CAH shares at $237.39 per share on 2026-08-19, as reported in the Form 4.

How many CAH shares in total did Mary C. Scherer sell in this filing?

The Form 4 shows that Mary C. Scherer sold a total of 2,302 Common Shares of CARDINAL HEALTH INC (CAH) across two sale transactions on 2026-08-19.

Does this CAH Form 4 indicate use of a Rule 10b5-1 trading plan?

No. The document-level Rule 10b5-1 checkbox is unchecked, so the reported sales by Mary C. Scherer are not affirmed as being made under a Rule 10b5-1 trading plan.

What is Mary C. Scherer’s role at CARDINAL HEALTH INC (CAH)?

Mary C. Scherer is identified in the Form 4 as the company’s Chief Accounting Officer, and she is the reporting person for the insider sales disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/20/2026 - 04:10 PM Accepted by SEC EDGAR 08/20/2026 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scherer Mary C.

(Last) (First) (Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN OHIO 43017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/19/2026		S		100	D	$237.4	5,013	D
Common Shares	08/19/2026		S		2,202	D	$237.39	2,811	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Amanda S. Pashi, Attorney-in-fact	08/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)